heaven cannot wait

while the pontiff deals with priests the oresident didpatches the faithful to heaven by practicing eorse than bad medicine and recruiting others to help him do so

go to boston and live lest you. are injured snd eorse at the ofgicial sl psy me f'amato hospital



Richard J. Murphy
President & CEO
As President and CEO, Mr. Murphy oversees all hospital operations. Mr. Murphy came to South Nassau from Richmond University Medical Center (RUMC) on Staten Island, where he served as President and Chief Executive Officer. His accomplishments include the execution of a successful financial post divestiture from St. Vincent's Catholic Medical Center of New York, which improved facility operating performance; and development of a strategic planning process to enhance physician partnerships, increase market share and expand capital reinvestment. His past experience also includes his leadership in Long Island's Catholic Health System, as the Executive Vice President of CHS's Suffolk Region hospitals, which included his serving as the Chief Executive Officer of Good Samaritan, St. Charles and St. Catherine of Siena hospitals. 





-----Original Message-----
From: Faustman Lab at Mass General Hospital <diabetestrial@partners.org>

Subject: Update from the Faustman lab

Updates from the Faustman Laboratory at Massachusetts General Hospital. November 15, 2018   Dear Friends, This was a monumental year at the Faustman Lab.  We published long-term data on patients from the BCG clinical trial program who have been followed for at least five years.  The results were published in Nature Vaccines and presented at eh 78th Scientific Sessions of the American Diabetes Association (ADA) as well as the 54th Annual Meeting of the European Association for the Study of Diabetes (EASD).  The positive feedback and media coverage was overwhelming.  EASD even scheduled a press conference to announce the results.  We also published the second edition of our book, BCG, TNF and Autoimmunity, which is based on the third international conference on BCG and autoimmune diseases.  The 150 patient Phase II trial is also proceeding; all 150 patients have received at least two doses of BCG or placebo.    BCG is a generic vaccine that holds the promise of an affordable treatment option for type 1 diabetics -- for patients of all means.  As you know, we are operating outside the traditional funding models for clinical trials because BCG is a generic drug.  All of our funding comes from private philanthropies and individuals who are impacted by the disease.  We are the open source approach to clinical trials -- a clinical trial by the people for the people. We have a lot of work to do before we can bring BCG to market with an FDA approved indication for type 1 diabetes.  We are also actively planning and enrolling new trials including a pediatric trial and an Expanded Access IND.  Anything you can do to help us meet our fundraising goals and turn our full attention back to the research is appreciated. Please follow us on Facebook and Twitter.  Here is a link to the latest newsletter from the lab Fall 2018 Newsletter for the Faustman lab. With Kind regards, Denise L. Faustman, MD, PhD Visit Our Homepage! Faustman Lab at Mass General Massachusetts General Hospital Charlestown, Massachusetts 02129 diabetestrial@partners.org 617-726-4084

Faustman Lab at Mass General, Massachusetts General Hospital, Building 149, 13th Street, Room 3602 , Charlestown, MA 02129 Update Profile | About our service provider Sent by diabetestrial@partners.org in collaboration with Try it free today Agreement between South Nassau and Mount Sinai finalized Mount Sinai is expected to provide $120 million to aid expansion of South Nassau Communities Hospital's campus in Oceanside.  South Nassau Communities Hospital in Oceanside is seen in February. Photo Credit: Newsday/J. Conrad Williams Jr.  By Delthia Ricksdelthia.ricks@newsday.comUpdated December 4, 2018 5:00 AM PRINT SHARE  After more than a year of negotiations and regulatory hurdles, the partnership between South Nassau Communities Hospital in Oceanside and Mount Sinai Health System in Manhattan has been finalized, executives for both health care institutions will announce Tuesday.  As part of the agreement, Mount Sinai will provide $120 million to aid expansion of South Nassau’s campus and services. This includes plans for a new four-story addition in Oceanside with an expanded emergency department, new intensive care beds and surgical suites.  Executives on both sides said the partnership blends a major academic research center with South Nassau’s community-based medicine on Long Island’s South Shore. Together, the institutions can offer clinical trials and a range of medical services that patients previously had to travel elsewhere on the Island or into Manhattan to receive, they said.  RECOMMENDED READING What are Long Island's top rated hospitals? “Mount Sinai is a world-class institution with a leading medical school, and this partnership will allow our patients to have access to some of the top physicians and most advanced treatments available,” Richard J. Murphy, South Nassau’s president and chief executive, said in a statement. “It also will help South Nassau reach the next level in our role as a growing regional medical center.” South Nassau is a 455-bed institution that has served Long Island’s South Shore since 1928. The cash from Mount Sinai will help lay the foundation for the hospital’s five-year master facility plan, which calls for greater expansion and increasing its footprint in the region.  Affiliation talks were first announced in May 2017, when executives on both sides of the partnership said they intended to explore a formal agreement that would align medical services, management and governance of the institutions.  South Nassau Communities Hospital officially became the Long Island flagship health care institution in the Mount Sinai system after a unanimous vote by the Oceanside hospital’s board of trustees in January. Get the Biz Briefing newsletter! The latest LI business news in your inbox Monday through Friday. Sign up By clicking Sign up, you agree to our privacy policy. “All of the regulatory approvals have been completed,” said Dr. Arthur Klein, president of the Mount Sinai Health Network.  Approvals of the new partnership have been made by the New York State Department of Health, the New York State Attorney General and the New York State Department of Education. What has yet to be decided, Klein said in an interview, is how the name of both institutions will be reflected in a renaming of South Nassau. New naming ultimately will reflect South Nassau’s status as the Long Island flagship of Mount Sinai, executives said. “We are working cooperately with South Nassau and a consulting firm [on renaming] that reflects the legacy of South Nassau as well as the alignment with Mount Sinai,” Klein said. “We are doing this in a way that is collaborative.” In a similar affiliation between NYU and the former Winthrop-University Hospital, a formalized agreement resulted in the Mineola institution being renamed NYU Winthrop Hospital. During the past 10 months, administrators at both institutions have been collaborating on aligning Mount Sinai’s academic, clinical and research expertise with South Nassau’s community-based system of care, Klein added. Mount Sinai specialists already have begun collaborating with physicians at South Nassau to provide more specialized, advanced care, Klein said. Approval has been granted by the Accreditation Council for Graduate Medical Education for a new internal medicine residency program on the South Nassau campus, which will train doctors in that key area of primary care, Klein said.